CL4H6, an ionizable cationic amino lipid with an apparent pKa of 6.35, has been utilized in creating lipid nanoparticles (LNPs). LNPs incorporating CL4H6 and carrying siRNA for Factor VII reduction in mice's liver levels and tumor-targeting siRNAs for CD45, STAT3, and HIF-1alpha in OS-RC-2 renal cancer mouse xenograft models demonstrate tumor volume reduction.
Products > Lipids In Drug Delivery > Advanced Lipid | Products > Lipids In Drug Delivery > Advanced Lipid > Advanced Lipid
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye